Detection and clinical significance of cd44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay

Applied Biochemistry and Biotechnology

Volumn 167, Issue 8, 2012, Pages 2257-2268

  Zhou, Gng ^a   Chiu, David ^a   Qin, Dajiang ^a   Niu, Lizhi ^a   Cai, Jinlei ^a   He, Lihua ^a   Huang, Wenhao ^a   Xu, Kecheng ^a  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

CD44v6; Integrin 1; Pancreatic cancer; Quantitative; Real time RT PCR

Indexed keywords

CD44V6; INTEGRINS; PANCREATIC CANCERS; QUANTITATIVE; REAL TIME RT-PCR;

DIAGNOSIS; DISEASES; GENES; PATHOLOGY; PROTEINS; TRANSCRIPTION; TUMORS;

POLYMERASE CHAIN REACTION;

BETA ACTIN; BETA1 INTEGRIN; CD44V6 ANTIGEN;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER METASTASIS; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, CD29; ANTIGENS, CD44; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84866430581     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9752-2     Document Type: Article

References (37)

1. Hirata, K., Egawa, S., Kimura, Y., Hantuy, R., & Niughi, T. (2007). Current status of surgery for PC. Digestive Surgery, 24, 137-141.
2. Carpelan, M., & Nordling, S. (2005). Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut, 54, 385-387.
3. Jemal, A., Siegel, R., & Ward, E. (2006). Cancer statistics. Cancer Journal for Clinicians, 56, 106-110.
4. Wagner, M., Redaelli, C., & Lietz, M. (2008). Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. British Journal of Surgery, 99, 586-589.
5. Ryu, J. K., Hong, S. M., & Karikari, C. A. (2010). Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 10, 66-73.
6. Hynes, R. O. (1992). Integrins: Versatility, modulation, and signaling in cell adhesion. Cell, 69, 11-17.
7. Holly, S. P., Larson, M. K., & Parise, L. V. (2000). Multiple roles of integrins in cell motility. Experimental Cell Research, 261, 69-74.
8. Jing, K., Qin, S., Zhi, L., & Niu, J. (2006). Expression of E-selectin, integrin-β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World Journal of Gastroenterology, 12, 3609-3611.
9. Yao, E. S., Zhang, H., & Chen, Y. Y. (2007). Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Research, 67, 659-664.
10. Yang, G. Y., Xu, K. S., & Pan, Z. Q. (2008). Integrin α-β6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Science, 99, 879-887.
11. Ylagan, L. R., Scholes, J., & Demopoulos, R. (2000). Cd44: A marker of squamous differentiation in adenosquamous neoplasms. Archives of Pathology & Laboratory Medicine, 124, 212-215.
12. Weber, G. F., Bronston, R. T., & Ilagan, J. (2002). Absence of the CD44 gene prevents sarcoma metastasis. Cancer Research, 62, 2281-2286.
13. Harburger, D. S., & Calderwood, D. A. (2009). Integrin signalling at a glance. Journal of Cell Science, 122, 159-163.
14. White, D. E. (2004). Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell, 6, 159-170.
15. Albelda, S. M. (2003). Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Laboratory Investigation, 68, 14-19.
16. Shibue, T., & Weinberg, R. A. (2009). Integrin beta1-focal adhesion kinase signaling directs the proliferation of cancer cells disseminated in the lungs. Proceedings of the National Academy of Sciences of the United States of America, 106, 10290-10295.
17. Zhong, L. P., Li, J., & Zhang, C. P. (2007). Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Archives of Oral Biology, 52, 740-747.
18. Rodrigo, J. P., Dominguez, F., & Alvarez, C. (2003). Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas. American Journal of Otolaryngology, 24, 384-389.
19. Rautava, J., Soukka, T., & Inki, P. (2003). CD44v6 in developing, dysplastic and malignant oral epithelia. Oral Oncology, 39, 373-379.
20. Kanke, M., Fujii, M., & Kameyama, K. (2000). Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. Archives of Otolaryngology-Head & Neck Surgery, 126, 1217-1223.
21. Vizoso, F. J., Fernández, J. C., & Corte, M. D. (2004). Expression and clinical significance of CD44v5 and CD44V6 in resectable colorectal cancer. Journal of Cancer Research and Clinical Oncology, 130, 679-680.
22. Yamamichi, K., Uehara, Y., & Kitamura, N. (1998). Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer. Cancer, 79, 256-262.
23. Ju, L., Zhou, C., & Li, W. (2009). Effect of integrin β1 up-regulation on the migration and adhesion capacity of lung cancer cell. Progress in Modern Biomedicine, 9, 3807-3812.
24. Brigitte, M., & Olivier, G. (2008). CD44s and CD44v6 expression in head and neck epithelia. PLoS One, 10, 234-237.
25. Chi, F., Wang, Z., Wang, S., Feng, D., & Gui, M. (2010). Expression of integrin beta1 in human gastric cardia adenocarcinoma tissues and their correlations with clinicalpathological significance. Chinese Journal of Cancer Prevention and Treatment, 17, 752-754.
26. Klatte, T., Seligson, D. B., & Rao, J. Y. (2010). Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. Journal of Urology, 183, 2403-2408.
27. Saito, H., Tsujitani, S., & Katano, K. (1998). Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Cancer, 83, 1094-1098.
28. Miyoshi, T., & Konda, K. (1997). The expression of the CD44 variant exon6 is associated with lymph node metastasis in non-small cell lung cancer. Clinical Cancer Research, 3, 1289-1292.
29. Niitsu, N., & Lijima, K. (2002). High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin lymphoma. Leukemia Research, 27, 241-243.
30. Zou, C., Song, G., Luo, Q., Yuan, L., & Yang, L. (2011). Mesenchymal stem cells require integrin β1 for directed migration induced by osteopontin in vitro. In Vitro Cellular & Developmental Biology. Animal, 47, 241-250.
31. Livak, K. J. (2001). Analysis of relative gene expression data using real-time quantitative PCR. Methods, 5, 402-408.
32. Pierga, J. Y., Bonneton, C., & Magdelenat, H. (2005). Real-time quantitative PCR determination of urokinasetype plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients. International Journal of Cancer, 114, 291.
33. Li, H., Guo, L., & Li, J. (2000). Expression of hyaluronan receptors CD44 and RHAMMin stomach cancers: Relevace with tumor progression. Oncologia, 17, 927-932.
34. Jung, T., Gross, W., & Zoller, M. (2011). CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance. Journal of Biological Chemistry, 286, 15862-15874.
35. Lau, M. T., Sok, W. K., & Leung, P. C. (2012). Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. Cancer Letters, 2, 136-138.
36. Yoshimasu, T., Sakurai, T., & Oura, S. (2004). Increased expression of integrin beta1 in highly brain metastatic subclone of human non small cell lung cancer cell line. Cancer Science, 95, 142-143.
37. Zhang, Y. (2005). The relation between CD44 and tumor development. Journal of Chinese Medical, 22, 343-346.